Company
iOmx Therapeutics
Advancing the Next Generation of Immuno-Oncology Therapies
Claim, correct or request removal
Record updated 23 September 2026
About
iOmx is a clinical-stage biotech company that harnesses deep tumor immunology insights to generate novel treatments for the most prevalent solid tumor indications. The company is translating unexplored immune evasion biology into a growing pipeline of biomarker-enabled drug programs.
Products
- Web
- IOMX-0235
- Web
- IOMX-0675
- Web
- OMX-0407
Loading relationship preview